# Phio Pharmaceuticals Corp.: Form 8-K, filed Sep 14, 2026

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2026-09-14
- Accepted by EDGAR: Sep 14, 2026, 12:59 ET
- Period: 2026-09-14
- Accession: 0001437749-26-030236
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000143774926030236/phio20260911_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000143774926030236/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000143774926030236/phio20260911_8k.htm

Filed Sep 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-030236. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.